NAVLE Hemic and Lymphatic

Bovine Trypanosomiasis Study Guide

African Animal Trypanosomiasis (AAT), also known as nagana, is a devastating protozoan disease of cattle caused by several species of Trypanosoma transmitted primarily by tsetse flies (Glossina spp.).

Overview and Clinical Importance

African Animal Trypanosomiasis (AAT), also known as nagana, is a devastating protozoan disease of cattle caused by several species of Trypanosoma transmitted primarily by tsetse flies (Glossina spp.). This disease represents one of the most significant constraints on livestock production in sub-Saharan Africa, causing annual economic losses estimated at over 1 billion USD.

The disease is characterized by intermittent fever, progressive anemia, weight loss, and lymphadenopathy. Trypanosomiasis affects the hemic and lymphatic systems through complex mechanisms involving immune-mediated hemolysis, erythrophagocytosis, and lymphoid hyperplasia followed by depletion.

High-YieldAnemia is the KEY clinical indicator in bovine trypanosomiasis and is better correlated with productivity loss than parasitemia. Treatment decisions in the field are often based on packed cell volume (PCV) rather than parasite detection.
Species Subgenus Location in Host Severity in Cattle
T. congolense Nannomonas Intravascular (microvasculature) Severe - Most important in East Africa
T. vivax Duttonella Intravascular (bloodstream) Moderate to Severe - Most important in West Africa
T. brucei brucei Trypanozoon Extravascular (tissues) Mild to Moderate in cattle

Etiology and Classification

Bovine trypanosomiasis is caused by flagellated protozoan parasites of the genus Trypanosoma. The three most important species affecting cattle in Africa are:

Major Trypanosome Species in Cattle

NAVLE TipT. congolense and T. vivax are INTRAVASCULAR parasites and do not cross the blood-brain barrier. T. brucei is EXTRAVASCULAR and can invade tissues including the CNS. This distinction explains why neurological signs are rare in cattle trypanosomiasis (predominantly T. congolense/T. vivax) but common in human sleeping sickness (T. brucei subspecies).
Tsetse Group Preferred Habitat Primary Trypanosome
G. morsitans (Morsitans group) Open woodland savanna T. congolense, T. brucei
G. palpalis (Palpalis group) Riverine/lake shore vegetation T. vivax, T. congolense
G. fusca (Fusca group) Dense forest areas T. vivax

Epidemiology and Transmission

Geographic Distribution

Tsetse-transmitted trypanosomiasis is endemic in sub-Saharan Africa, affecting approximately 10 million square kilometers across 37 countries. The distribution is determined by tsetse fly habitat, which includes woodland savannas, riverine forests, and gallery forests.

T. vivax has extended beyond Africa to South America and the Caribbean, where it is transmitted mechanically by biting flies (tabanids, Stomoxys) in the absence of tsetse.

Vector Biology: Tsetse Flies

Tsetse flies (genus Glossina) are the biological vectors for African trypanosomes. Key characteristics include:

  • Both male and female flies are obligate blood feeders
  • Viviparous reproduction - females deposit fully developed larvae
  • Feed every 2-3 days on vertebrate hosts
  • Lifespan of 1-3 months, producing 8-12 offspring

Major Tsetse Fly Species and Habitats

Transmission Cycle

Cyclical transmission occurs through tsetse flies:

  • Tsetse ingests bloodstream trypomastigotes during blood meal on infected host
  • Parasites transform to procyclic forms in fly midgut and multiply
  • Migration to mouthparts (T. vivax, T. congolense) or salivary glands (T. brucei)
  • Development of infective metacyclic trypomastigotes (3-4 weeks)
  • Injection of metacyclics into new host during subsequent blood meal
High-YieldT. vivax has the SHORTEST development cycle in tsetse (restricted to mouthparts only), while T. brucei has the LONGEST (requires migration to salivary glands). This means T. vivax can also be transmitted MECHANICALLY by biting flies, explaining its presence in South America where tsetse are absent.
Mechanism Description
Erythrophagocytosis Hyperactivated macrophages in spleen, liver, and bone marrow phagocytose both parasitized and non-parasitized RBCs. This is the PRIMARY mechanism.
Immune-mediated hemolysis IgM-antigen complexes deposit on RBC surfaces, leading to complement activation and extravascular hemolysis
Hemodilution Chronic infections cause plasma volume expansion, contributing to apparent anemia
Dyserythropoiesis Iron sequestration and inflammatory cytokines impair effective erythropoiesis despite bone marrow hyperplasia
Hemorrhage (T. vivax) Acute hemorrhagic syndrome with thrombocytopenia can cause widespread bleeding in some T. vivax strains

Pathophysiology

Mechanisms of Anemia

Anemia is the hallmark clinical feature of bovine trypanosomiasis. Multiple mechanisms contribute:

Antigenic Variation and Immune Evasion

African trypanosomes evade host immunity through antigenic variation of their Variable Surface Glycoprotein (VSG) coat. Key points:

  • VSG coat covers entire parasite surface (10 million copies per cell)
  • Genome contains approximately 1,000 VSG genes
  • Parasites can switch to new VSG type before immune clearance
  • Results in waves of parasitemia (relapsing pattern)
  • Makes vaccine development extremely challenging
NAVLE TipThe fluctuating parasitemia pattern (waves of high then low parasitemia) is characteristic of trypanosomiasis and results from antigenic variation. Each wave represents a new VSG variant escaping antibody-mediated clearance. This explains why NO VACCINE exists for bovine trypanosomiasis.

Effects on Lymphoid System

Trypanosomiasis causes profound changes to lymphoid tissue:

  • Early infection: Lymphoid hyperplasia with B-cell proliferation and hypergammaglobulinemia
  • Chronic infection: Lymphoid depletion and profound immunosuppression
  • Splenomegaly: Due to erythrophagocytosis and extramedullary hematopoiesis
  • Lymphadenopathy: Particularly superficial lymph nodes (prescapular, prefemoral)
System Clinical Findings
General Intermittent fever (39-41C), progressive weight loss, weakness, lethargy, emaciation, rough/staring coat, loss of tail brush hair
Hemic Pale mucous membranes (anemia - KEY SIGN), watery blood appearance, petechiae (T. vivax hemorrhagic syndrome)
Lymphatic Generalized lymphadenopathy (especially superficial nodes), splenomegaly, edema (submandibular, ventral)
Ocular Lacrimation, ocular discharge, corneal opacity/cloudiness (especially T. vivax - can cause blindness)
Reproductive Abortion at any stage of pregnancy, infertility, reduced libido in bulls, decreased milk production
Integumentary Skin tightly drawn over ribs/pelvis, loss of skin turgor, chancre at bite site (early infection)

Clinical Signs and Presentation

The incubation period is typically 1-4 weeks. Disease presentation varies from acute to chronic depending on trypanosome species, virulence, and host factors.

Clinical Signs by System

Method Procedure Sensitivity/Notes
Wet blood film Fresh blood under coverslip; observe motile trypanosomes Low sensitivity; good for high parasitemia
Thin blood smear Giemsa-stained smear; allows species identification Low sensitivity; essential for species ID
Thick blood smear Giemsa-stained; concentrates parasites Higher sensitivity than thin smear
Buffy coat/HCT (Woo) Centrifuge in hematocrit tube; examine buffy coat-plasma junction with phase contrast HIGH SENSITIVITY - preferred field method; also provides PCV
Dark-ground buffy coat Express buffy coat onto slide; dark-ground illumination Highest sensitivity of direct methods

Diagnosis

Parasitological Methods

Direct parasite detection remains the gold standard for diagnosis:

Serological and Molecular Methods

  • ELISA (antibody detection): Useful for herd screening; remains positive after treatment
  • Antigen-ELISA: Detects circulating antigens; greater than 90% sensitivity; becomes negative after successful treatment
  • PCR: Highest sensitivity; species-specific; limited field availability
  • CATT (Card Agglutination Test): Rapid field test; primarily for T. brucei group

Hematological Findings

Laboratory abnormalities in bovine trypanosomiasis include:

  • Anemia: PCV commonly falls to 15-20% (normal 24-46%); initially regenerative, becomes non-regenerative
  • Leukopenia: Lymphopenia and neutropenia common
  • Thrombocytopenia: Contributes to hemorrhagic tendencies in acute T. vivax
  • Hypergammaglobulinemia: Polyclonal B-cell activation; IgM markedly elevated
  • Hypoalbuminemia: Due to chronic inflammation and protein loss
High-YieldThe BUFFY COAT TECHNIQUE (Woo method) is the MOST SENSITIVE field diagnostic method. It simultaneously provides PCV measurement (for anemia assessment) and allows parasite detection at the buffy coat-plasma interface. A PCV less than 25% in endemic areas is highly suggestive of trypanosomiasis.
Drug Dose Route Use Notes
Diminazene aceturate 3.5-7 mg/kg IM Therapeutic First-line curative; rapid clearance; some prophylaxis (approx 2 weeks)
Isometamidium chloride 0.5-1 mg/kg Deep IM Prophylactic/ Therapeutic Forms depot at injection site; protection 2-4 months; local reaction common
Homidium chloride/bromide 1 mg/kg IM Therapeutic Active against T. congolense and T. vivax; some prophylactic activity
Quinapyramine 3-5 mg/kg SC Therapeutic/ Prophylactic Best for T. brucei/T. evansi; severe local reactions; 3-4 month protection

Treatment

Only a limited number of trypanocidal drugs are available. All have narrow therapeutic indices, making accurate dosing essential.

Trypanocidal Drugs for Cattle

NAVLE TipDIMINAZENE aceturate is the first-line CURATIVE drug (sanative). ISOMETAMIDIUM is preferred for PROPHYLAXIS due to its depot effect providing longer protection. Drug RESISTANCE is an increasing problem - if treatment fails, consider switching drug class rather than increasing dose.
Method Description
Insecticide-treated cattle (ITC) Pyrethroid dips, sprays, or pour-ons applied to cattle; most cost-effective method; deltamethrin is commonly used
Insecticide-treated targets Blue and black cloth panels impregnated with insecticide; attract and kill tsetse; odor-baited for improved efficacy
Traps Biconical or pyramidal traps for monitoring and mass trapping; can be odor-baited
Sterile Insect Technique (SIT) Release of irradiated sterile male flies; successfully eliminated tsetse in Zanzibar; expensive
Bush clearing Removal of tsetse habitat; environmentally controversial but historically effective

Prevention and Control

Vector Control Strategies

Trypanotolerant Cattle

Certain West African Bos taurus breeds exhibit trypanotolerance - an innate ability to remain productive despite trypanosome infection:

Breed Origin Characteristics
N'Dama West Africa (Guinea) Most trypanotolerant; small-medium size; longhorn; approximately 3.5 million head
West African Shorthorn West Africa Smaller than N'Dama; moderate tolerance; includes Muturu, Baoulé
Zebu (Bos indicus) Asia/East Africa SUSCEPTIBLE - high mortality without treatment; includes Boran, Gobra

Differential Diagnosis

The non-specific clinical signs of trypanosomiasis overlap with several other conditions:

  • Anaplasmosis: Hemolytic anemia with fever; RBC inclusions on blood smear
  • Babesiosis: Hemolytic anemia, hemoglobinuria; intraerythrocytic piroplasms visible
  • Theileriosis: Lymphadenopathy, anemia; Koch's blue bodies in lymphocytes; schizonts in lymph node smears
  • Chronic fasciolosis: Weight loss, anemia; submandibular edema; eggs on fecal exam
  • Haemonchosis: Anemia in small ruminants/young cattle; bottle jaw; eggs on fecal exam
  • Malnutrition/starvation: Weight loss without fever; no parasitemia; history of feed shortage

Prognosis

  • Untreated: Usually fatal in susceptible breeds; chronic debilitation with eventual death
  • Treated early: Good prognosis; PCV recovery within 2-4 weeks; productivity resumes
  • Chronic/advanced cases: Guarded; may clear infection but permanent organ damage possible
  • Drug-resistant infections: Poor unless alternative effective drug available

Zoonotic Considerations

T. brucei rhodesiense, which causes acute human African trypanosomiasis (East African sleeping sickness), can use cattle as a reservoir host. Key points:

  • Cattle may carry T. b. rhodesiense asymptomatically while serving as a source of human infection
  • Mass treatment of cattle with trypanocides has been used as a One Health intervention to reduce human sleeping sickness
  • T. congolense and T. vivax are NOT zoonotic - they do not infect humans

Practice NAVLE Questions

Test your knowledge with 10,000+ exam-style questions, detailed explanations, and timed exams.

Start Your Free Trial →